These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 25363021)
1. Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein. Schwarzenbach H; Eichelser C; Steinbach B; Tadewaldt J; Pantel K; Lobanenkov V; Loukinov D BMC Cancer; 2014 Nov; 14():796. PubMed ID: 25363021 [TBL] [Abstract][Full Text] [Related]
2. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters. Wischnewski F; Friese O; Pantel K; Schwarzenbach H Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428 [TBL] [Abstract][Full Text] [Related]
3. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943 [TBL] [Abstract][Full Text] [Related]
4. Expression of BORIS in melanoma: lack of association with MAGE-A1 activation. Kholmanskikh O; Loriot A; Brasseur F; De Plaen E; De Smet C Int J Cancer; 2008 Feb; 122(4):777-84. PubMed ID: 17957795 [TBL] [Abstract][Full Text] [Related]
5. Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells. Kang Y; Hong JA; Chen GA; Nguyen DM; Schrump DS Oncogene; 2007 Jun; 26(30):4394-403. PubMed ID: 17260018 [TBL] [Abstract][Full Text] [Related]
6. Alternative promoters of gene MAGE4a. De Plaen E; Naerhuyzen B; De Smet C; Szikora JP; Boon T Genomics; 1997 Mar; 40(2):305-13. PubMed ID: 9119398 [TBL] [Abstract][Full Text] [Related]
7. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944 [TBL] [Abstract][Full Text] [Related]
8. Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1. Santiago FS; Khachigian LM Circ Res; 2004 Sep; 95(5):479-87. PubMed ID: 15297375 [TBL] [Abstract][Full Text] [Related]
9. Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor. Li S; Wang Q; Qiang Q; Shan H; Shi M; Chen B; Zhao S; Yuan L J Cancer Res Clin Oncol; 2015 Nov; 141(11):1909-20. PubMed ID: 25773124 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional protein Sp1 regulates LEDGF transcription by directly interacting with its cis-elements in GC-rich region of TATA-less gene promoter. Singh DP; Bhargavan B; Chhunchha B; Kubo E; Kumar A; Fatma N PLoS One; 2012; 7(5):e37012. PubMed ID: 22615874 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the human reduced folate carrier in childhood acute lymphoblastic leukemia cells. Liu M; Ge Y; Payton SG; Aboukameel A; Buck S; Flatley RM; Haska C; Mohammad R; Taub JW; Matherly LH Clin Cancer Res; 2006 Jan; 12(2):608-16. PubMed ID: 16428507 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions. Williams AO; Isaacs RJ; Stowell KM BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886 [TBL] [Abstract][Full Text] [Related]
13. [BORIS Regulates SOCS3 Expression Through Epigenetic Mechanisms in Human Hepatocellular Carcinoma Cells]. He JY; Liu QY; Wei L; Liu ZJ; Huang Y; Yu XQ; Li B; Qin Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):1-7. PubMed ID: 29737080 [TBL] [Abstract][Full Text] [Related]
14. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells. Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells. Estève PO; Chin HG; Pradhan S J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180 [TBL] [Abstract][Full Text] [Related]
17. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma. Yan Y; Dalmasso G; Sitaraman S; Merlin D Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546 [TBL] [Abstract][Full Text] [Related]
19. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736 [TBL] [Abstract][Full Text] [Related]
20. MAGEA1 inhibits the expression of BORIS via increased promoter methylation. Zhao J; Wang Y; Liang Q; Xu Y; Sang J J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30498011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]